Allianz Asset Management
EPZM

Allianz Asset Management’s Epizyme, Inc EPZM Stock Holding History

Allianz Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-31,985
Closed -$266K – 2690
2021
Q2 		$266K Hold
31,985
– – ﹤0.01% 2288
2021
Q1 		$279K Sell
31,985
-228,567
-88% -$2.37M ﹤0.01% 2056
2020
Q4 		$2.83M Sell
260,552
-34,404
-12% -$424K ﹤0.01% 1217
2020
Q3 		$3.52M Buy
294,956
+9,615
+3% +$129K ﹤0.01% 1090
2020
Q2 		$4.58M Buy
285,341
+18,664
+7% +$326K 0.01% 1246
2020
Q1 		$4.14M Buy
266,677
+152,897
+134% +$3.28M 0.01% 1236
2019
Q4 		$2.8M Buy
113,780
+51,308
+82% +$762K ﹤0.01% 1732
2019
Q3 		$641K Sell
62,472
-46
-0.1% -$580 ﹤0.01% 2289
2019
Q2 		$784K Buy
+62,518
New +$804K ﹤0.01% 2229
2015
Q3 		– Sell
-311,000
Closed -$7.46M – 2461
2015
Q2 		$7.46M Sell
311,000
-214,000
-41% -$4.12M 0.01% 1224
2015
Q1 		$9.86M Buy
+525,000
New +$10.8M 0.01% 958

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Allianz Asset Management's EPZM Position: Q3 2021 in Review

Allianz Asset Management sold out of Epizyme, Inc (EPZM) in Q3 2021, closing a stake of 31,985 shares — an estimated $266K sold.

Allianz Asset Management first reported a position in EPZM in Q1 2015 and held it in 11 quarters. The position peaked at $9.86M in Q1 2015. 116 funds tracked by Wall St. Rank hold EPZM as of Q3 2021.

  • Allianz Asset Management reported no remaining Epizyme, Inc position as of Q3 2021 after selling out during the quarter.
  • Allianz Asset Management sold 31,985 Epizyme, Inc shares in Q3 2021, an estimated $266K.
  • Allianz Asset Management first reported a position in Epizyme, Inc in Q1 2015 and held it in 11 quarters.
  • Allianz Asset Management's Epizyme, Inc position peaked at $9.86M in Q1 2015.
  • 116 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2021.

Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.